Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment ceased in phase III NSCLC study of Sarasar

Feb. 10, 2004

Novel steroid sulphate inhibitor for breast tumor therapy reported

Feb. 10, 2004

AP-5346 makes preclinical and clinical progress

Feb. 9, 2004

Alimta approved for use with cisplatin for malignant pleural mesothelioma

Feb. 9, 2004

Orphan drug status for BCX-1777 for T-cell non-Hodgkin's lymphoma

Feb. 9, 2004

DepoCyte launched in Europe

Feb. 9, 2004

French team reports novel proapoptitic and antiangiogenic agents for cancer therapy

Feb. 9, 2004

Abbott and Caprion collaborate on drug discovery for lung cancer

Feb. 9, 2004

Phase I ThermoDox protocol amendments allowed

Feb. 6, 2004

IP3R3 involved in peritoneal metastasis of gastric cancers

Feb. 6, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.